4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Cellulite: new trials by email Literature Review of Cellulite trials Research Report on Cellulite
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real World CCH Study in Adult Females With Cellulite EN3835 - Edematous Fibrosclerotic Panniculopathy (EFP), Cellulite | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 153 | 2019-11-01 | 2022-02-22 |
| Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite) CCH-aaes, Observation - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 483 | 2018-04-26 | 2023-09-08 |
| Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women EN3835, Placebo - Edematous Fibrosclerotic Panniculopathy (Cellulite) | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 422 | 2018-02-08 | 2020-10-08 |
| Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women EN3835, Placebo - Edematous Fibrosclerotic Panniculopathy (Cellulite) | Phase 3 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 423 | 2018-02-05 | 2020-10-08 |
Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Skin Manifestations (4)
Observation (1)
Endo USA Inc., a Keenova Therapeutics Company (4)
United States (4) · Puerto Rico (1)
Michael McLane (2) · David Hernandez (1) · Karen Chajko (1)